期刊文献+

Pravastatin alleviates lipopolysaccharide-induced placental TLR4 over-activation and promotes uterine arteriole remodeling without impairing rat fetal development 被引量:7

Pravastatin alleviates lipopolysaccharide-induced placental TLR4 over-activation and promotes uterine arteriole remodeling without impairing rat fetal development
下载PDF
导出
摘要 Preeclampsia is associated with over-activation of the innate immune system in the placenta,in which toll-like receptor 4(TLR4) plays an essential part.With their potent anti-inflammatory effects,statins have been suggested as potential prevention or treatment of preeclampsia,although evidence remains inadequate.Herewith,we investigated whether pravastatin could ameliorate preeclampsia-like phenotypes in a previously established lipopolysaccharide(LPS)-induced rat preeclampsia model,through targeting the TLR4/NF-κB pathway.The results showed that pravastatin reduced the blood pressure [maximum decline on gestational day(GD) 12,(101.33±2.49) mmHg vs.(118.3±1.37) mmHg,P〈0.05] and urine protein level [maximum decline on GD9,(3,726.23± 1,572.86) μg vs.(1,991.03 ±609.37)μg,P〈 0.05],which were elevated following LPS administration.Pravastatin also significantly reduced the rate of fetal growth restriction in LPS-treated rats(34.10% vs.8.99%,P〈0.05).Further pathological analyses suggested a restoration of normal spiral artery remodeling in preeclampsia rats by pravastatin treatment.These effects of pravastatin were associated with decreased TLR4/NF-κB protein levels in the placenta and IL-6/MCP-1 levels in serum.Additionally,no obvious abnormalities in fetal liver,brain,and kidney were found after administration of pravastatin.These results provide supportive evidence for use of pravastatin in preventing preeclampsia. Preeclampsia is associated with over-activation of the innate immune system in the placenta,in which toll-like receptor 4(TLR4) plays an essential part.With their potent anti-inflammatory effects,statins have been suggested as potential prevention or treatment of preeclampsia,although evidence remains inadequate.Herewith,we investigated whether pravastatin could ameliorate preeclampsia-like phenotypes in a previously established lipopolysaccharide(LPS)-induced rat preeclampsia model,through targeting the TLR4/NF-κB pathway.The results showed that pravastatin reduced the blood pressure [maximum decline on gestational day(GD) 12,(101.33±2.49) mmHg vs.(118.3±1.37) mmHg,P〈0.05] and urine protein level [maximum decline on GD9,(3,726.23± 1,572.86) μg vs.(1,991.03 ±609.37)μg,P〈 0.05],which were elevated following LPS administration.Pravastatin also significantly reduced the rate of fetal growth restriction in LPS-treated rats(34.10% vs.8.99%,P〈0.05).Further pathological analyses suggested a restoration of normal spiral artery remodeling in preeclampsia rats by pravastatin treatment.These effects of pravastatin were associated with decreased TLR4/NF-κB protein levels in the placenta and IL-6/MCP-1 levels in serum.Additionally,no obvious abnormalities in fetal liver,brain,and kidney were found after administration of pravastatin.These results provide supportive evidence for use of pravastatin in preventing preeclampsia.
出处 《The Journal of Biomedical Research》 CAS CSCD 2018年第4期288-297,共10页 生物医学研究杂志(英文版)
基金 funded by the following Grants:National Natural Science Foundation of China,Grant/Award Number:81370724,81571463 and 81401225 Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province for the year 2016,Grant/Award Number:KYLX16_1111
关键词 PREECLAMPSIA arteriole remodeling pravastatin toll-like receptor 4 fetal development preeclampsia arteriole remodeling pravastatin toll-like receptor 4 fetal development
  • 相关文献

参考文献1

二级参考文献10

  • 1Adams Waldorf KM,Persing D,Novy MJ, et al.Pre- treatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in Rhesus monkeys[].Re- prod Sci.2008
  • 2Hashimoto C,Hudson KL,Anderson KV.The Toll gene of drosophila, required for dorsal-venial embryonic po- larity, appears to encode a transmembrane protein[].Cell.1988
  • 3Kim YM,Romero R,Oh SY,Kim CJ, et al.Toll-like receptor 4: a potential link between "danger signals", the innate immune system, and preeclampsia[].American Journal of Pathology.2005
  • 4Akira S,Takeda K,Kaisho T.Toll-like receptors: critical proteins linking innate and acquired immunity[].Nature Immunology.2001
  • 5Hallman M,Ramet M,Ezekowitz R A.Toll-like receptors as sensors of pathogens[].Pediatrics Research.2001
  • 6Xu Y,Tao X,Shen B,et al.Structural basis for signal transduction by the Toll/interleukin-1 receptor domains[].Nature.2000
  • 7Petroff,MG.Immune interactions at the maternal-fetal interface[].Journal of Reproductive Immunology.2005
  • 8Tsan MF,Baochong G.Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors[].Journal of Endotoxin Research.2007
  • 9Miller SI,Ernst RK,Bader MW.LPS, TLR4 and infectious disease diversity[].Nature Reviews Microbiology.2005
  • 10Medvedev AE,Piao W,Shoenfelt J,et al.Role of TLR4tyrosine phos-phorylation in signal transduction and endotoxin tolerance[].Journal of Biological Chemistry.2007

共引文献5

同被引文献36

引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部